Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
2013 | A PROSPECTIVE COHORT STUDY OF MULTIPLE RISK FACTORS AND AGE AT ONSET OF HEPATOCELLULAR CARCINOMA IN HEPATITIS B VIRUS CARRIERS | Hung, Y. -C.; Lin, C. -L.; Liu, C. -J.; Chen, C. -J.; Liaw, Y. -F.; Chang, H. -C.; Lin, S. -M.; Lee, S. -D.; Chen, P. -J.; Yu, M. -W. | J. Hepatol. | | | |
2013 | A PROSPECTIVE COHORT STUDY OF MULTIPLE RISK FACTORS AND AGE AT ONSET OF HEPATOCELLULAR CARCINOMA IN HEPATITIS B VIRUS CARRIERS | Hung, Y. -C.; Lin, C. -L.; Liu, C. -J.; Chen, C. -J.; Liaw, Y. -F.; Chang, H. -C.; Lin, S. -M.; Lee, S. -D.; Chen, P. -J.; Yu, M. -W.; 于明暉 | J. Hepatol. | | | |
2014 | SPONTANEOUS SEROCLEARANCE OF HBsAg IN HEPATITIS B VIRUS/HEPATITIS C VIRUS DUALLY INFECTED PATIENTS: A 10-YEAR FOLLOW-UP | Liu, C. -J.; Wu, L. -W.; Tseng, T. -C.; Yang, W. -T.; Su, T. -H.; Yang, H. -C.; Liu, C. -H.; Kao, J. -H.; Chen, D. -S.; Chen, P. -J. | J. Hepatol. | | | |
2012 | SUSTAINED HCV CLEARANCE AND INCREASED HBSAG SEROCLEARANCE IN PATIENTS WITH DUAL CHRONIC HEPATITIS C AND B POST-PEGINTERFERON ALFA-2A AND RIBAVIRIN TREATMENT: A 5-YEAR FOLLOW-UP | Liu, C. -J.; Chuang, W. -L.; Lee, C. -M.; Yu, M. -L.; Lu, S. -N.; Wu, S. -S.; Liao, L. -Y.; Chen, C. -L.; Kuo, H. -T.; Chao, Y. -C.; Tung, S. -Y.; Yang, S. -S.; Kao, J. -H.; Liu, C. -H.; Su, W. -W.; Lin, C. -L.; Chen, P. -J.; Chen, D. -S. | J. Hepatol. | | | |
2012 | SUSTAINED HCV CLEARANCE AND INCREASED HBSAG SEROCLEARANCE IN PATIENTS WITH DUAL CHRONIC HEPATITIS C AND B POST-PEGINTERFERON ALFA-2A AND RIBAVIRIN TREATMENT: A 5-YEAR FOLLOW-UP | Liu, C. -J.; Chuang, W. -L.; Lee, C. -M.; Yu, M. -L.; Lu, S. -N.; Wu, S. -S.; Liao, L. -Y.; Chen, C. -L.; Kuo, H. -T.; Chao, Y. -C.; Tung, S. -Y.; Yang, S. -S.; Kao, J. -H.; Liu, C. -H.; Su, W. -W.; Lin, C. -L.; Chen, P. -J.; Chen, D. -S.; 陳定信; 劉振驊; 高嘉宏; 劉俊人; 陳培哲; 陳祈玲 | J. Hepatol. | | | |
2016 | TG-2349, A POTENT PROTEASE INHIBITOR, PLUS PEGIFN/RBV PROVIDES EXCELLENT VIROLOGICAL RESPONSES FOR HARDER-TO-TREAT SUBPOPULATIONS OF HCV-1B NON-CIRRHOTIC PATIENTS | Yu, M. -L.; Hsu, S. -J.; Yeh, C. -T.; Hung, C. -H.; Chen, M. -Y.; Chen, P. -J.; Huang, Y. -H.; Cheng, P. -N.; Chen, C. -M.; Chang, L. -W.; Lin, C. -C.; Sheen, F.; King, C. -H. R.; Kuo, E.; Hsu, M. -C.; 陳培哲 | Journal of Hepatology | 0 | 0 | |
2014 | THE CRISPR/Cas9 SYSTEM FACILITATES ELIMINATION OF THE PERSISTENT INTRAHEPATIC HBV GENOMES IN VIVO | Yang, H. -C.; Lin, S. -R.; Liu, C. -J.; Kao, J. -H.; Chen, D. -S.; Chen, P. -J.; 陳定信; 高嘉宏; 楊宏志; 劉俊人; 陳培哲 | J. Hepatol. | | | |